‘Going Beyond’ – Celltrion USA Explains How It Is Building On Biosimilars

Executives Discuss Innovation, Latest Launches And Streamlining

 
• By Dave Wallace
  
Celltrion is aiming to move up the value chain in the US biologics market (Shutterstock)

More from Interviews

More from Leadership